Cargando…
A review of methods used in assessing non-serious adverse drug events in observational studies among type 2 diabetes mellitus patients
Clinical drug trials are often conducted in selective patient populations, with relatively small numbers of patients, and a short duration of follow-up. Observational studies are therefore important for collecting additional information on adverse drug events (ADEs). Currently, there is no guidance...
Autores principales: | Hakobyan, Liana, Haaijer-Ruskamp, Flora M, de Zeeuw, Dick, Dobre, Daniela, Denig, Petra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3198877/ https://www.ncbi.nlm.nih.gov/pubmed/21958008 http://dx.doi.org/10.1186/1477-7525-9-83 |
Ejemplares similares
-
Construct and concurrent validity of a patient-reported adverse drug event questionnaire: a cross-sectional study
por: de Vries, Sieta T, et al.
Publicado: (2014) -
A Longitudinal Study Examining Adherence to Guidelines in Diabetes Care According to Different Definitions of Adequacy and Timeliness
por: Sidorenkov, Grigory, et al.
Publicado: (2011) -
Trends in hyperlipidemia and hypertension management in type 2 diabetes patients from 1998–2004: a longitudinal observational study
por: Greving, Jacoba P, et al.
Publicado: (2007) -
Do Treatment Quality Indicators Predict Cardiovascular Outcomes in Patients with Diabetes?
por: Sidorenkov, Grigory, et al.
Publicado: (2013) -
Differential Effects of Comorbidity on Antihypertensive and Glucose-Regulating Treatment in Diabetes Mellitus – A Cohort Study
por: Voorham, Jaco, et al.
Publicado: (2012)